8-Alkylamino-substituted analogs of N6-cyclopentyladenosine are partial agonists for the cardiovascular adenosine A1 receptors in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 800-808

  Van Schaick, E A ^a   Mathot R A A ^a   Gubbens Stibbe, J M ^a   Langemeijer, M W E ^b   Roelen, H C P F ^a   Ijzerman, A P ^a   Danhof, M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Sylvius Laboratories ^*

Author keywords

[No Author keywords available]

Indexed keywords

6 N CYCLOPENTYLADENOSINE; ADENOSINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ADENOSINE; ANIMALS; BLOOD PRESSURE; GUANOSINE TRIPHOSPHATE; HEART RATE; MALE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030783720     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 2 receptors. Eur. J. Pharmacol. 196: 69-76, 1991.
2. 6-cyclopentyladenosine and 8-cyclopentyltheophylline. Br. J. Pharmacol. 115: 1253-1259, 1995.
3. BELARDINELLI, L., LINDEN, J. AND BERNE, R. M.: The cardiac effects of adenosine. Prog. Cardiovasc. Dis. 22: 73-97, 1989.
4. BELARDINELLI, L. AND ISENBERG, G.: Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ. Res. 53: 287-297, 1983.
5. 1 receptor ligands. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 267: 55-61, 1994.
6. BRUNS, R. F.: Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can. J. Physiol. Pharmacol. 58: 673-691, 1980.
7. COFFIN, V. L. AND SPEALMAN, R. D.: Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys. J. Pharmacol. Exp. Ther. 241: 76-83, 1986.
8. 1-adenosine receptors in guinea pig atrioventricular node. Am J. Physiol. 262: H661-H671, 1992.
9. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br. J. Pharmacol. 109: 3-5, 1993.
10. GIBALDI, M. AND PERRIER, D.: Non-compartmental analysis based on statistical moment theory. In Pharmacokinetics, 2nd ed., pp. 409-424, Marcel Dekker Inc., New York, 1982.
11. 3 receptor-mediated hypotension in the rat. Br. J. Pharmacol. 115: 945-952, 1995.
12. HOLFORD, N. H. G. AND SHEINER, L. B.: Kinetics of pharmacological response. Pharmacol. Ther. 16: 143-166, 1982.
13. IJZERMAN, A. P., VAN DER WENDEN, E. M., VON FRIJTAG DRABBE KÜNZEL, J. K, MATHOT, R. A. A., DANHOF, M., BOREA, P. A. AND VARANI, K.: Partial agonism of theophylline-7-riboside on adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 350: 638-645, 1994.
14. 2) receptors. In Comprehensive Medicinal Chemistry of the Rational Design, Mechanistic Study and Therapeutic Application of Chemical Compounds, ed. by C. Hansch, P. G. Sammes and J. B. Taylor, vol. 3: Membranes and Receptors, ed. by J. C. Emmett, pp. 601-642, Pergamon Press, New York, 1990.
15. JACOBSON, K. A., VAN GALEN, P. J. M. AND WILLIAMS, M.: Adenosine receptors: Pharmacology, structure-activity relationships, and therapeutic potential. J. Med. Chem. 35: 407-422, 1992.
16. KENAKIN, T. P.: Pharmacological Analysis of Drug-Receptor Interaction, pp. 441-468, Raven Press, New York, 1993.
17. KENT, R. S., DE LEAN, A. AND LEFKOWITZ, R. J.: A quantitative analysis of beta-adrenergic receptor interactions: Resolution of high and low affinity states of the receptor by computer modelling of ligand binding data. Mol. Pharmacol. 17: 14-23, 1980.
18. 3 adenosine receptors, J. Med. Chem. 37: 3614-3621, 1994.
19. 1 adenosine receptors: Persistent activation reveals spare receptors. Mol. Pharmacol 30: 403-409, 1986.
20. 1 agonist potency and efficacy in G protein activation and adenylate cyclase inhibition. Drug Dev. Res. 37: 128, 1996.
21. 1 antagonist 8-cyclopentyltheophylline and its application in a pharmacokinetic study in rats J. Chromatogr. 620: 113-120, 1993.
22. 6-cyclopentyladenosine in the rat. J. Pharmacol. Exp. Ther. 268: 616-624, 1994.
23. 1 receptor in vivo. Br. J. Pharmacol. 116: 1957-1964, 1995.
24. 1 receptor in vivo. J. Pharmacol. Exp. Ther. 279: 1439-1446, 1996.
25. 1 selective adenosine agonist, RG14202. J. Pharmacol. Exp. Ther. 265: 699-706, 1993.
26. MULLANE, K. M. AND WILLIAMS, M.: Adenosine and cardiovascular function. In Adenosine and adenosine receptors, ed. by M. Williams, pp. 289-333, Humana, New Jersey, 1990.
27. OLSSON, R. A., KHOURI, E. M., BEDYNEK, J. L. AND MCLEAN, J.: Coronary vaso-activity of adenosine in the conscious dog. Circ. Res. 45: 468-478, 1979.
28. 1 receptors. J. Med. Chem. 39: 1463-1471, 1996.
29. 1 adenosine receptor-G protein coupling in bovine brain membranes: effects of guanine nucleotides, salt, and solubilization. J. Neurochem. 51: 1592-1598, 1988.
30. STRUYKER BOUDIER, H. A. J.: Kinetics and dynamics of cardiovascular drug action: Introduction. In The in Vivo Study of Drug Action, ed. by C. J. van Boxtel, N. H. G. Holford and M. Danhof, pp. 217-229, Elsevier Science Publishers, Amsterdam, 1992.
31. VAN DER WENDEN, E. M., VON FRIJTAG DRABBE KÜNZEL, J. K., MATHOT, R. A. A., DANHOF, M., IJZERMAN, A. P. AND SOUDIJN, W.: Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor. J. Med. Chem. 38, 4000-4006, 1995a.
32. 1 receptor. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 290: 189-199, 1995b.
33. 3 receptors. J. Med. Chem. 39: 2980-2989, 1996.
34. 6-(p-sulfophenyl)adenosine in rats. Br. J. Pharmacol., in press.
35. 3 receptor agonist 2-Cl-IB-MECA in conscious rats. Eur. J. Pharmacol. 308: 311-314, 1996a.
36. 6-cyclopentyladenosine derivatives in rats. Drug. Dev. Res. 37: 128, 1996b.
37. WEBB, R. L, MCNEAL, R. B., BARCLAY, B. W. AND YASAY, G. D.: Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat. J. Pharmacol. Exp. Ther. 254: 1090-1099, 1990.
38. YAMOAKA, K., NAKAGAWA, T. AND UNO, T.: Application of Aikaike's information criterion (AIC) in the evaluation of linear pharmacokinetics. J. Pharmacokin. Biopharm. 6: 165-175, 1978.